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 This thesis examines the chemistry of 1-benzazepines and the possibility of alkylation by 
electrophilic addition.  Due to the lack of previous research on this subject, there is a great deal 
of work that can be done to explore the reactivity of these compounds.  It has recently been 
suggested that 1-benzazepines are intermediates in the synthesis of prospective analogues of β-
chemokine receptor CCR5 antagonists for treatment of HIV/AIDS.  The method for producing 
these treatment drugs, however, is not very effective or efficient.  A new process proposed by my 
mentor is a more direct synthesis of CCR5 antagonists and the information presented in this 
thesis lays the groundwork for this method.  The goal in the following experiments was to find a 
way to add alkyl and other groups to C3 of the benzazepine after generating a benzazepine anion.  
The success of this work would allow for greater variation in the later preparation of analogues 
of CCR5 antagonists.  The synthesis methods we used generated an anion at a low temperature 
of -65°C.  Four different electrophiles were successfully added to the benzazepine using our 
reaction methods. The expected deprotonation and addition site was C3, due to the previously 
established stability of the 3H-1-benzazepine.  The first attempt with deuterium as an 
electrophile provided hopeful results, as it was present in significant levels at C3 after the 
addition.  A methyl group added only at C3 of the benzazepine, while a benzyl group seemed to 
attach at the nitrogen atom, and at both C3 and C5.  p-Anisaldehyde gave the product of the 
reaction at either C3 or C5, as either 3- or 5-methoxy-benzyl alcohol.  An additional finding was 
the ability of the methyl group to lock in the conformation of the molecule, since this did not 








 HIV, human immunodeficiency virus, is estimated to affect 56,300 Americans each year 
with new infections.[1]  Although this number has been seemingly stable over the years, it is still 
a devastating fact of life.  As a retrovirus, HIV causes the slow deterioration of an individual’s 
immune system by destroying CD4+ T cells, which are involved in fighting diseases in the 
body.[1]  These cells are essentially the means by which HIV spreads, as it replicates within them.  
In most untreated cases, 10-15 years after becoming infected with HIV, the virus develops into 
AIDS.[2]  With the advent of antiretroviral drugs, however, this transformation has been slowing 
down. 
 Antiretroviral drugs are medications used as a form of treatment for HIV.[2]  When 
several of them are used in combination with each other, the method is called highly active 
antiretroviral treatment or HAART.[3]  HAART works by inhibiting certain steps of the HIV 
replication process, which leads to a reduction of HIV in the blood.[3]  Due to the fast replication 
of T cells, however, HIV often mutates and forms a resistance to treatment drugs.  The basis for 
HAART is that the treatment is strength in numbers, with a mixture of 3 or 4 drugs working 
together to lower HIV levels.[3]  HAART has been successful in reducing the reproducing power 
of HIV, but it has yet to wipe out the virus completely.  There are other issues with the drugs 
used in HAART in that they can be quite toxic and harmful.  Therefore, it is clearly of extreme 
importance that research continues developing a more effective and efficient drug to fight HIV. 
 HIV has a specific process by which it invades cells and begins to reproduce more virus 
particles.  A component that is extremely critical to the success of the HIV particle fusing with a 
cell is the CCR5 co-receptor, a beta chemokine receptor.[4]  CCR5 is a protein found on T cells 
that facilitates HIV infection and serves as a means for HIV to enter T cells.  Fusion between the 
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viral envelope and the CD4+ cell membrane can only occur when the HIV particle is bound to 
both CD4 and this co-receptor.  CCR5 also plays a key role in how HIV can progress into 
AIDS.[5]  More important than the CCR5 co-receptor’s role in HIV infection, however, is its 
function as a drug target. 
 Research of the CCR5 co-receptor has actually encountered a type of mutation, called the  
CCR5-Delta32 mutation.[5]  This is a mutation in the CCR5 gene, which doesn’t produce a 
functional protein. A person that is homozygous for CCR5-Delta32 has almost complete 
protection against HIV-1 infection. A heterozygous individual also shows some resistance to 
HIV infection.  Therefore, a further study of CCR5 is essential because individuals with mutated 
receptors are still normal, while resisting infection to some degree.  This thesis focuses on laying 
the groundwork for potential synthesis of related analogues of CCR5 antagonists that may cause 
this same effect of HIV resistance. 
 The specific work of this thesis involves the generation of alkylated-1-benzazepines, 
which are potential intermediates in the synthesis of the CCR5 antagonist and analogues.  These 
1-benzazepines have not been thoroughly studied, but their role in this process has significant 
potential.  The results of this project prove that 1-benzazepines will successfully react to create a 
variety of derivatives of the molecule, which could lead to further advances in CCR5 antagonists.  










Introduction                                                                                   
 
A significant component necessary for HIV replication is the β-chemokine co-receptor 
CCR5.[4]  Previous research has demonstrated that individuals with a non-functional receptor, 
due to a mutation of the gene, are resistant to strains of HIV-1 infection.[6-9]  Studies of a CCR5 
antagonist in treatment drugs are currently underway.  The 1-benzazepine core (highlighted in 











The synthetic route to this molecule is plagued by low yields in several of the steps.[6-9]  If a new 
and more efficient method could be determined to synthesize this compound to directly target the 
virus and cause less damage to the body, this could make a significant medical impact.   
 Dr. Keith Ramig and Dr. Edyta Greer have proposed an improved synthesis of this 



























In order for this synthesis to be implemented in the future, much background work will have to 
be carried out to probe new chemistry that these 1-benzazepines might undergo.  The hope is not 
only to be able to prepare the drug molecule above, but also analogues with closely related 
structures.  It is possible that one of these analogues could have more beneficial properties than 1 
itself.  The chemistry of 3H-1-benzazepines such as 5 has not been well studied in the literature, 
so considerable research will have to be performed to probe the reactivity and usefulness of these 
compounds as possible intermediates in the synthesis of the CCR5 antagonist and analogues. 
In one of the few studies that has been carried out recently, Ramig et al. were able to 
prepare a variety of 1-benzazepines by a novel method, to be discussed more in detail 
below.[10,11]  One of the study’s shortcomings was its inability to produce benzazepines that have 
anything but hydrogen atoms at C3.  This would not allow versatility in the eventual preparation 
of analogues of antagonist 1.  The goal of my thesis is to redress this shortcoming by finding a 
way to place substituents such as alkyl groups at C3 of the benzazepines, after the benzazepine 





























9A (X = D)
9B (X = CH3)
9C (X = CH2Ph)





We propose that a benzazepine anion should be obtainable from a benzazepine by treatment with 
a strong base such as lithium diisopropylamide (LDA), and that the anion should react with 
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compounds such as alkyl halides and aldehydes to give a new benzazepine with either an alkyl 
group or an α-hydroxyalkyl group at C3.  These kinds of alkyl groups are the most commonly 
used type of varied substituents when evaluating the pharmacology of a series of prospective 
drug molecules. 
Our research is based on the method used by Ramig et al. involving 2-fluoroaniline 10 
and an aryl vinyl ketone 11 (Scheme 3).[10,11]  The reaction was a single flask procedure that 
produced 1-benzazepines in useful yields.  With this procedure, they created benzazepines with 
different substituents through the use of appropriately substituted aryl vinyl ketones.  These gave 
3H-1-benzazepines 12 with varying groups on C2, C4, and C5.  Initially the 5H-1-benzazepine 
13 seemed to form, but this rearranged to give the 3H-1-benzazepine 12, which was more stable.  
As discussed previously, the synthesis failed when attempts were made to place an alkyl group at 






Additionally, only a few others have contributed to the research on benzazepines.  
Scheme 3 (shown above) was based on the results of Brooke and Matthews,[12] who observed 
this mechanism first.  They used aromatic amines, in which all the carbons were fluorinated, and 
acetophenone to generate very low yields of benzazepines.[12]  Singh and Batra demonstrated the 
synthesis of substituted 1H and 3H-1-benzazepines using SnCl2 reduction of nitro groups on 
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alkanoates.[13]  When they varied the groups at C2 and C4 of the benzazepine, they observed that 
the substituents affected which isomer formed.  Similarly, Kharraz et al. explored other areas of 
benzazepine synthesis.  They successfully examined the possible rearrangements of the 1H to the 
5H-1-benzazepine and the 5H to the 3H-1-benzazepine.[14,15]  In one study, 5H-1-benzazepines 
14 were rearranged to the 3H-1-benzazepines 16.  In a different study, 3H-1-benzazepines 16 
were prepared by two synthetic pathways: the chemical oxidation of the 2,5- and 2,3-dihydro-
1H-1-benzazepines and the rearrangement of the 5H-1-benzazepines 14.[15]  The yields in these 





The fact that the 5H-1-benzazepine isomerizes to the 3H-1-benzazepine with the help of a strong 
base (Scheme 4) is significant because it implies deprotonation.  This is relevant to the main 
focus of this thesis because a benzazepine anion was generated by deprotonation and then 
alkylated, as in Scheme 2 above.  The isomerization also supports the finding that the 3H-1-
benzazepine is the most stable.  
The benzazepine molecules can be examined with the help of azepine studies as well.  
Streef’s research on azepines, which are simpler cousins of benzazepines, proves to be very 
valuable to us, and has given research on benzazepines a new direction in which to grow.[16]  The 
study examined the possibility of adding electrophiles to azepines.  Streef was able to 
deprotonate the 2-diethylamino-5-phenyl-3H-azepine 17 in a solution of 1,2-dimethoxyethane by 
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LDA, in ether under nitrogen and at room temperature, to generate an azepine anion 18.[16]  After 
this, the introduction of an alkyl halide or other electrophiles was successful in adding a new 



























 These electrophiles E included D2O with a 75% yield, methyl iodide, dimethyl disulfide, 
and benzyl bromide all with 60-65% yields.[16]  The results of this reaction demonstrated that 
azepines could be deprotonated by LDA and then alkylated at C3.  It is apparent that substitution 
at carbon three is still the most stable form of the molecule, as no alkylation was seen at the other 
possible sites of C5 and N1.  The promising data from this experiment paved the way for a 
similar study using benzazepines.  Only a few various groups were used in the reaction and 
actually added to the ring, but the success of the experiment gave us basis on which to build.  
With this research as a guideline, we prepared a similar reaction for our benzazepine and 
achieved interesting results of our own. 
We have been successful in generating a benzazepine anion 8 (Scheme 2), which 
involved removing a proton from the ring to leave it negatively charged.  With the negative 
charge, the positively charged electrophile became attracted to the ring and reacted with it.  In 
this way, a new carbon-carbon bond was formed.  The next step was ascertaining where the 
electrophiles ended up on the ring, after reacting with the anion.  There was the possibility that 
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they would end up on the nitrogen atom, at C3, or at C5.  As we already established the 3H-1-
benzazepine as the most stable form, we were able to see how these additions ended up affecting 
the stability of the molecule.  More importantly, the successful synthesis of these 1-benzazepines 
proved that it might be possible to generate CCR5 antagonist analogues more efficiently. 
 
Results and Discussion 
 
Synthesis of deuterated benzazepine 9A 
Initially, the reactions of the benzazepine anion 8 and various alkyl groups were designed 
following the results of Streef,[16] but had to be modified and adapted as the experiments 
proceeded.  The first reaction with D2O was attempted at room temperature, then at 0°C, and 
finally at -65°C.  Initially excess LDA was used as demonstrated by Streef’s results.  We 
believed it was necessary in order to fully deprotonate the benzazepine and force the reaction to 
the right, rather than remain in equilibrium.  However, as shown by the results we found that this 
was not required.  The first reaction at room temperature and with excess LDA gave a 30% yield 
of 3D-1-benzazepine.  The following D2O experiments were changed to be a 1:1 molar ratio of 
benzazepine and LDA.  As we attempted this, however, we found that the reaction was occurring 
similar to a titration.  The LDA was not immediately deprotonating the benzazepine after the first 
drop, and it actually took a varying amount to generate the anion.  Essentially, the color change 
to dark green (presumably the color of the benzazepine anion) had to occur first and then the 1 
equivalent of LDA was added.  In the second reaction, the NMR analysis of the crude reaction 
mixture showed the characteristic CH2 peak of the benzazepine, but with an integration value of 
1.  This meant that it was representing only one hydrogen and that the other had been replaced by 
a deuterium.  After recrystallization, however, NMR showed mainly 3H-1-benzazepine 7.  Thus 
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the purified compound had either regained the protium during purification, or the analysis of the 
crude mixture was faulty. 
 The next D2O reaction occurred at 0°C but again, NMR analysis determined that only 
20% of the 3H had been replaced by a deuterium.  One reason for the low yield could be that the 
plate during chromatography acted as an acid, replacing some of the deuterium with protium.  
Additionally, the 3D-1-benzazepine 9A present was in equilibrium with 5D-1-benzazepine 
making it difficult for peak integration measurement.  The last reaction attempted with D2O was 
performed at -65°C and NMR showed the presence of 15% 3D-1-benzazepine 9A.  It was 
determined that -65°C was the optimal temperature for the reaction because at low temperatures 
there were fewer by-products.   
Four attempts were made to achieve a significant level of deuterium incorporation.  The 
highest level of deuterium seen across all the experiments was about 30%.  We found later, by 
control experiments, that deuterium was being lost during the required chromatographic 
purification.  But the fact that any deuterium was seen was a good indication that the proposed 
anion was being formed. 
 
 
Synthesis of methylated benzazepine 9B 
Methyl iodide was the second electrophile attempted in this experiment.  During the first 
trial, NMR of the crude sample immediately demonstrated some success.  There was a quartet 
around 2.6 ppm, which was the hydrogen at C3, and a doublet at around 1.0 ppm representing 
the CH3 group in 3-methyl-1-benzazepine 9B.  Interestingly, it was also discovered that the 
molecule was not undergoing a fast conformational change.  Normally with the unsubstituted 
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3H-1-benzazepine 7, the NMR spectrum shows that the non-planar azepine ring is undergoing a 
conformational change (i.e. ring-flipping) in solution at a relatively fast rate.  However, the 
methyl group at C3 on the benzazepine 9B seems to lock the molecule into one conformation.  It 
was thought that by lowering the temperature, the peak would sharpen as the transformation 
would have slowed down, but this wasn’t the case.  It was then thought that heat would make the 
peak broader, but this was also not the case.  Therefore, the conformational change was not 
occurring.  Radial chromatography using 2.5% EtOAc/hexane gave a mixed fraction of 3-
methyl-1-benzazepine 9B and 3H-1-benzazepine 7.  A second radial chromatography using 1% 
EtOAc/hexane provided a good separation.  NMR showed the 3-methyl-1-benzazepine 9B with 
very slight impurities and recrystallization using hexane produced yellow crystals with a melting 
point of 109-111°C. 
 Another trial of the methylation reaction produced better results when the reaction time 
was extended.  After the addition of LDA, an hour was allowed to elapse before adding methyl 
iodide and after adding it, another hour was allowed to pass.  The crude oil of this reaction 
became a solid at room temperature.  Radial chromatography using 1% EtOAc/hexane gave a 3-
methyl-1-benzazepine 9B sample that was 96.5% pure and the melting point was 106-107°C.  
After two recrystallizations with hexane, large yellow crystals formed with a melting point 
between 109-111°C.  All of the crystals combined gave a 43% recovery rate for the reaction. 
 The last reaction with methyl iodide was scaled up to create a greater amount of product.  
Additionally, the crude mixture was washed twice with water and ether for a better yield.  NMR 
of this crude sample showed barely any 3H-1-benzazepine 7, with the majority of the product 
being 3-methyl-1-benzazepine 9B.  After radial chromatography, NMR of the product showed 
only 4.5% 3H-1-benzazepine and mainly 3-methyl-1-benzazepine 9B.  The 30% yield for this 
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reaction was the best yield produced for the methylation reaction.  X-ray analysis of crystals 
confirmed that the methyl group was attached to the benzazepine at C3 and that it was locked 
into a specific conformation (see ORTEP Diagram). 
 
ORTEP Diagram of 9B 
 
 
Synthesis of benzylated benzazepine 9C 
 The third electrophile attempted was benzyl bromide, which proved to give complicated 
results.  The initial TLC (10% EtOAc/hexane) of the crude sample showed the 3H-1-benzazepine 
7 spot as well as another spot above it, believed to be 3-benzyl-1-benzazepine 9C, with a 
significant amount of space between them. Proton NMR showed as expected the benzazepine 
starting material, plus two compounds with the spectral characteristics predicted for a benzylated 
benzazepine, a downfield doublet (CH next to CH2) and an upfield doublet (CH2).  This is 
consistent with benzylation having occurred at both C3 and C5.  If benzylation occurs at C5, 












The first radial chromatography produced 2 fractions: fraction 1 contained a benzylated isomer 
and an unknown, fraction 2 contained 3H-1-benzazepine 7 and the other benzylated isomer. 
Preliminary NMR data shows that the unknown in fraction 1 is most likely the 1-benzyl-1-
benzazepine 21.  Recrystallization of both fractions from ethyl acetate/hexane helped to further 
isolate and separate the components.  Fraction 1 crystals were of the 1-benzyl isomer with a 
sharp melting point of 131-133°C.  Although the proton NMR revealed the structure 21, the 
compound was submitted for X-ray analysis to prove this.  The filtrate contained an inseparable 
mixture (see list of TLC solvents used below) of the 1-benzyl-1-benzazepine, and either the 3-
benzyl-1-benzazepine or 5-benzyl-1-benzazepine isomer.  Fraction 2 crystals were the 3H-1-
benzazepine 7 and fraction 2 filtrate was a mix of 7 and the other benzylated isomer. 
Radial chromatography required these TLC eluents be tested on both fractions above: 
30% CH2Cl2/hexane, 2% isopropyl alcohol/hexane, 1% isopropyl alcohol/hexane, 10% 
Et2O/hexane, 100% benzene, 100% toluene, 50% toluene/hexane, 25% benzene/hexane, 50% 
benzene/hexane, and 75% benzene/hexane.  100% Benzene for fraction 2 crystals and filtrate 
was the only solvent that showed a good separation; however, 50% and 25% were less polar and 
the spots didn’t move as fast so a compromise was chosen for radial chromatography.  40% 
Benzene/hexane eluent was first chosen for radial chromatography because the spots needed to 
separate at a good rate.  A sample of one of the benzylated isomers was produced in about 95% 
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purity.  Another attempt using 50% benzene/hexane gave a sample of about 99% purity.  After 
recrystallization from ethyl acetate/hexane, the compound was in the form of light yellow 
needles and had a melting point of 123-124°C.  This has been submitted for X-ray 
crystallography analysis. 
The NMR spectra of both fractions were used to calculate the percent yield of all four 
compounds in the original crude sample.  The peak locations and integration values were utilized 
to form a ratio between the crystals and filtrates of each fraction, which allowed us to come up 
with the percent and thereby, mass of each component.  Fraction one consisted of 79% 1-benzyl-
1-benzazepine and 21% of either 3-benzyl-1-benzazepine 9C or 5-benzyl-1-benzazepine 20.  A 
comparison to the theoretical yields of these compounds then enabled us to determine that there 
was 35% yield of 1-benzyl-1-benzazepine 21 and 9% yield of either of the other isomers (i.e. 9C 
or 20) out of the total original sample.  Fraction two contained 42% of the 3H-1-benzazepine 7 
starting material and 58% of either 3-benzyl-1-benzazepine 9C or 5-benzyl-1-benzazepine 20.  
Again using the theoretical yields, it was calculated that there was a 23% recovery of 3H-1-
benzazpine, the starting material, and a 43% yield of one of the 3- or 5-benzylated isomers in the 
crude mixture.  Together these yields add up to a theoretically impossible value of 110% (35%, 
9%, 23%, 43%), which may be an indication that there are other compounds present that we 
don’t know about.  Despite this, the overall reaction generated a significant amount of new 
products, and showed that in contrast to methyl iodide, which gave only one of the three possible 
alkylated isomers, benzyl bromide gave all three.  The reasons for this are at present a mystery, 





Synthesis of α-hydroxy alcohol benzazepine 9D 
 The final electrophile attempted in this experiment was p-methoxybenzaldehyde also 
known as p-anisaldehyde.  A TLC (10% EtOAc/hexane) of the crude product, as well as of the 
workup mixture later, showed that there were two products to isolate.  The NMR spectra of the 
crude sample showed the presence of anisaldehyde with a singlet peak at 10 ppm and a peak at 4 
ppm, representing a methoxy group.  Although we are unsure whether the p-methoxybenzyl 
alcohol added to C3 or C5, either way a new chiral center was created.  This can cause analysis 
of the product to be complicated.   
 Radial chromatography led to the isolation of two new compounds.  NMR analysis of 
compound one showed a methoxy group, an alcohol, and aromatics that confirmed the presence 








Compound two proved to be difficult to dissolve for NMR analysis.  It was separated into two 
NMR samples: sample one with methanol-d, DMSO-d6, and acetic acid-d4 as solvents; and 
sample two with solely acetic acid-d4 as a solvent.  Sample one did not give a solution, so it was 
dissolved in CH2Cl2, and washed with 10 mL of NaHCO3 and 10 mL of water.  The CH2Cl2 layer 
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was isolated and under reduced pressure gave a yellow film.  This was recrystallized from ethyl 
acetate/hexane.  NMR analysis of the crystals showed similarities to compound one.  Both 
spectra have three peaks between 3.6 ppm and 5 ppm with equal integration values.  The 
difference, however, is in the chemical shifts of the peaks in each of the spectra.  We suspect that 
compound one and compound two crystals are the 3- and 5-methoxy-benzyl alcohol isomers 9D 
and 22, but at this point it is impossible to say which is which. 
NMR sample two, of compound two, showed the presence of anisaldehyde and two 
unknowns.  One of these may be either 9D or 22.  After it was left overnight in the acidic NMR 
solvent, we found that one of the unknown compounds (9D or 22) had started to convert back to 
anisaldehyde.  After three days, another NMR showed an increase in the amount of 
anisaldehyde.  This sample was then washed with 10 mL of NaHCO3 and 10 mL of CH2Cl2, and 
the CH2Cl2 layer was isolated under reduced pressure.  This was also recrystallized from ethyl 
acetate/hexane.  A further analysis by TLC and NMR showed that the 3H-1-benzazepine starting 
material may be present in addition to anisaldehyde, however, this could not be confirmed.  At 











Experimental                                                                                                                    
 
Deprotonation and Alkylation of the 3H-1-benzazepine 7 


















7 8  
 
General Method: The reaction occurred at three different temperatures: room temperature, 0°C, 
and -65°C.  To a flame-dried 3-neck reaction flask under nitrogen was added 1 mmol (295 mg) 
of 3H-1-benzazepine 7.  This was followed by 10.0 mL of  anhydrous THF.  A 1:1 mole ratio of 
LDA solution (2.0 M) to benzazepine/THF solution was used.  1 mmol (0.5 mL) of LDA was 
added after using enough LDA to first turn the content green (presumably creation of anion 8).  
After 15 minutes, 1.0 mL of D2O was added to the flask and the solution became a dark 
brown/red.  The solution was partitioned between 15.0 mL of H2O and 15.0 mL of ether in a 
separatory funnel.  Drying over CaCl2 and removal of the solvents under reduced pressure gave 
the product in the form of yellow viscous oil.  Before and after chromatographic purification 
(radial chromatography, 10% ethyl acetate/hexane) the product was analyzed by proton NMR 
(CDCl3 solvent) to determine the extent of deuterium content, as judged by the diminution of the 



























7 8 9B  
General Method: The reaction occurred at -65°C using a dry ice 2-propanol slush bath.  To a 
flame-dried 3-neck reaction flask under nitrogen was added 1 mmol (295 mg) of 3H-1-
benzazepine 7.  This was followed by 10.0 mL of THF.  A 1:1 mole ratio of LDA solution (2.0 
M) to benzazepine/THF solution was used.  1 mmol (0.5 mL) of LDA was added after using 
enough LDA to first turn the content green (presumably creation of anion 8).  After 30 minutes, 
CH3I was added in ratio to the total amount of LDA used.  The slush bath was removed and 
immediately the solution color changed to a light green, followed by a light orange.  At -33°C, it 
became a dark orange and at -4°C, it was a deep red.  The solution finally settled as a cloudy 
yellow at 16°C.  After 10 minutes at room temperature, the solution was then partitioned 
between 15.0 mL of H2O and 15.0 mL of ether in a separatory funnel.  The organic layer was 
dried over CaCl2 and the solvents were removed under reduced pressure to give the crude 
product as yellow viscous oil.  The product was purified by radial chromatography on silica gel 
(1 mm plate, 1% ethyl acetate/hexane) and then later recrystallized from ethyl acetate/hexane to 




























7 8 9C  
 
General Method: The reaction occurred at -65°C using a dry ice 2-propanol slush bath.  To a 
flame-dried 3-neck reaction flask under nitrogen was added 2 mmol (590 mg) of 3H-1-
benzazepine 7.  This was followed by 20.0 mL of THF.  A 1:1 mole ratio of LDA solution (2.0 
M) to benzazepine/THF solution was used.  2 mmol (1.0 mL) of LDA was added after using 
enough LDA to first turn the content green (presumably creation of anion 8).  After 1 hour, 
benzyl bromide was added in ratio to the 2 mmol of LDA used.  The slush bath was removed and 
the solution remained a dark green until -16°C, when it changed to a red/brown color.  At -10°C, 
the solution was red/orange and at -7°C, it was a dark orange.  Eventually, the solution became a 
cloudy yellow at 20°C.  After 10 minutes at room temperature, the solution was then partitioned 
between 15.0 mL of H2O and 15.0 mL of ether in a separatory funnel.  The organic layer was 
dried over CaCl2 and the solvents were removed under reduced pressure to give the crude 
product as yellow viscous oil.  The crude product was purified by radial chromatography on 
silica gel (4 mm plate, 2%, 5% ethyl acetate/hexane) to give two fractions and both were 
recrystallized from ethyl acetate/hexane.  Vacuum filtration separated each fraction into crystals 
and filtrates.  Further radial chromatography (1 mm plate, 50% benzene/hexane) and 
recrystallization were performed on the fraction 2 filtrate.  A second recrystallization purified the 
 
22 
fraction 1 filtrate.  Isolated were 151 mg 1-benzylated isomer 21 (21% yield) as yellow solid, 40 
mg less-polar 3- or 5-benzylated isomer 9C or 20 as a yellow solid (9% yield), 187 mg more-
polar 3- or 5-benzylated isomer 9C or 20 as a yellow solid (43% yield), and 135 mg of 3H-1-
benzazepine starting material 7 as a yellow solid (23% recovery). 
 





















General Method: The reaction occurred at -65°C using a dry ice 2-propanol slush bath.  To a 
flame-dried 3-neck reaction flask under nitrogen was added 2 mmol (590 mg) of 3H-1-
benzazepine 7.  This was followed by 20.0 mL of THF.  A 1:1 mole ratio of LDA solution (2.0 
M) to benzazepine/THF solution was used.  2 mmol (1.0 mL) of LDA was added after using 
enough LDA to first turn the content green (presumably creation of anion 8).  After 1 hour, p-
anisaldehyde was added in ratio to the 2 mmol of LDA used.  Upon addition, the solution 
changed color to brown.  The slush bath was removed and the solution changed color again at -
51°C to dark orange.  An hour later, at 20°C, the solution was just orange.  After 10 minutes at 
room temperature, the solution was then partitioned between 15.0 mL of H2O and 15.0 mL of 
ether in a separatory funnel.  The organic layer was dried over CaCl2 and the solvents were 
removed under reduced pressure to give the crude product as yellow viscous oil.  The product 
was purified by radial chromatography on silica gel (4 mm plate, 15% ethyl acetate/hexane) to 
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give two isolated fractions of interest.  The solvents in each fraction were removed under 
reduced pressure and both were recrystallized from ethyl acetate/hexane.  Fraction one oiled out 
after recrystallization twice, and was again recrystallized in an attempt to isolate it.  Fraction two 
was separated into two NMR samples: sample one with methanol-d, DMSO-d6, and acetic acid-
d4 as solvents; and sample two with solely acetic acid-d4 as a solvent.  Sample one was 
recrystallized from ethyl acetate/hexane to give 6 mg of crystals.  Sample two could not be 
isolated.  Purification of these samples continues. 
 
Conclusion      
  
The deprotonation and electrophilic addition to the benzazepine molecule provides a new 
window of options for benzazepine synthesis.  Deuteration experiments were initially used 
during attempts to optimize deprotonation conditions.  The anion could be generated at 
temperatures as low as -65°C.  A significant level of deuterium incorporation indicated the 
presence of the anion 8.  Then, the alkylating agents methyl iodide and benzyl bromide were 
used to place either a methyl group or benzyl group on the benzazepine.  In the case of methyl 
iodide, methylation occurred cleanly at C3 as expected and yielded 9B.  The greatest yield out of 
all three trials with this electrophile was 30% of a yellow crystalline solid, melting point 109-
111°C.  Additionally, the methyl group at C3 locked the molecule into one conformation and no 
conformational change was occurring.  This was determined by running NMR analysis at 
different temperatures, and observing no change in the spectrum.  In the case of benzyl bromide, 
benzylation occurred at both C3 and C5, plus an unknown compound was produced.  We now 
know that the unknown is most likely the 1-benzylated isomer, but X-ray analysis is being 
performed to confirm this.  Recrystallization was able to purify the 1-benzyl-1-benzazepine 
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crystals, with a melting point between 131-133°C.  The more polar benzylated isomer has also 
been purified as a yellow crystalline solid with a melting point of 123-124°C, but the less polar 
isomer has thus far only been obtained in an impure state.   
The final electrophile, p-anisaldehyde, resulted in two isomers at C3 and C5 as well.  An 
initial separation of the crude product gave two different fractions.  Fraction one is still being 
recrystallized, but NMR shows the presence of either 3- or 5-methoxy-benzyl alcohol.  Fraction 
two was split into two NMR samples.  Sample one was eventually recrystallized and NMR 
analysis of the crystals showed comparable peaks to fraction one, thus it is believed to be the 
other isomer of 3- or 5-methoxy-benzyl alcohol.  Sample two could not be isolated because there 
was not enough product to analyze. 
The ability to add different alkyl groups to the molecule allows for versatility in 
producing 1-benzazepine derivatives.  Future studies with other electrophiles will provide further 
insight on this.  This will lead to the eventual preparation of analogues of the CCR5 antagonist.  
Additionally, the fact that substituting a hydrogen atom with a methyl group caused the 
conformation of the molecule to lock into one position is an interesting find because this was not 
the case for the unsubstituted 3H-1-benzazepine.  Further studies of how other groups affect the 
conformation of the molecule will provide a better understanding of this.  The study of a 
molecule’s conformation is important because it can affect its reactivity and pharmacological 
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Data Tables of the Crystal Structure 
Table 1.  Crystal data and structure refinement for KR21111.  
   
   
      Identification code               kr21111  
   
      Empirical formula                 C23 H19 N  
   
      Formula weight                    309.39  
   
      Temperature                       296(2) K  
   
      Wavelength                        0.71073 A  
   
      Crystal system, space group       Orthorhombic,  Aba2  
   
      Unit cell dimensions              a = 13.2591(4) A   alpha = 90 deg.  
                                        b = 25.5247(7) A    beta = 90 deg.  
                                        c = 10.0154(3) A   gamma = 90 deg.  
   
      Volume                            3389.56(17) A^3  
   
      Z, Calculated density             8,  1.213 Mg/m^3  
   
      Absorption coefficient            0.070 mm^-1  
   
      F(000)                            1312  
   
      Crystal size                      0.50 x ?0.50 x 0.40 mm  
   
      Theta range for data collection   2.21 to 27.49 deg.  
   
      Limiting indices                  -17<=h<=16, -33<=k<=33, -13<=l<=12  
   
      Reflections collected / unique    16219 / 3853 [R(int) = 0.0356]  
   
      Completeness to theta = 27.49     99.5 %  
   
      Absorption correction             None  
   
      Refinement method                 Full-matrix least-squares on F^2  
   
      Data / restraints / parameters    3853 / 1 / 218  
   
      Goodness-of-fit on F^2            1.054  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0361, wR2 = 0.0896  
   
      R indices (all data)              R1 = 0.0455, wR2 = 0.0946  
   
      Absolute structure parameter      0.00  
   





         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic  
         displacement parameters (A^2 x 10^3) for KR21111.  
         U(eq) is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           U(eq)  
         ________________________________________________________________  
   
          N(1)         9304(1)       8324(1)        969(1)       52(1)  
          C(2)         9278(1)       8731(1)       1711(2)       48(1)  
          C(3)        10204(1)       9053(1)       2085(2)       52(1)  
          C(4)        10830(1)       8717(1)       3014(2)       48(1)  
          C(5)        11212(1)       8258(1)       2591(2)       51(1)  
          C(6)        11059(1)       8010(1)       1303(2)       52(1)  
          C(7)        10181(1)       8078(1)        522(1)       52(1)  
          C(21)        8269(1)       8895(1)       2214(2)       51(1)  
          C(22)        7408(1)       8706(1)       1584(2)       68(1)  
          C(23)        6460(1)       8851(1)       2005(2)       85(1)  
          C(24)        6345(2)       9178(1)       3069(2)       84(1)  
          C(25)        7171(2)       9362(1)       3719(2)       82(1)  
          C(26)        8133(1)       9222(1)       3299(2)       65(1)  
          C(41)       11028(1)       8912(1)       4383(2)       49(1)  
          C(42)       11130(1)       8574(1)       5460(2)       58(1)  
          C(43)       11340(1)       8761(1)       6724(2)       68(1)  
          C(44)       11444(1)       9288(1)       6942(2)       71(1)  
          C(45)       11343(1)       9630(1)       5900(2)       73(1)  
          C(46)       11142(1)       9446(1)       4632(2)       65(1)  
          C(31)       10774(1)       9263(1)        868(2)       67(1)  
          C(13)       11811(1)       7674(1)        817(2)       62(1)  
          C(14)       11735(2)       7442(1)       -421(2)       68(1)  
          C(15)       10894(2)       7524(1)      -1199(2)       69(1)  
          C(16)       10115(1)       7824(1)       -718(2)       62(1)  





           Table 3.  Selected bond lengths [A] and angles [deg] for KR21111.  
           _____________________________________________________________  
   
            N(1)-C(2)                     1.2776(18)  
            N(1)-C(7)                     1.3964(19)  
            C(2)-C(21)                    1.489(2)  
            C(2)-C(3)                     1.5236(19)  
            C(3)-C(4)                     1.5137(19)  
            C(3)-C(31)                    1.532(2)  
            C(4)-C(5)                     1.344(2)  
            C(4)-C(41)                    1.482(2)  
            C(5)-C(6)                     1.451(2)  
            C(6)-C(13)                    1.403(2)  
            C(6)-C(7)                     1.413(2)  
            C(7)-C(16)                    1.403(2)  
            C(13)-C(14)                   1.377(3)  
            C(14)-C(15)                   1.376(3)  
            C(15)-C(16)                   1.374(2)  
   
            C(2)-N(1)-C(7)              125.12(12)  
            N(1)-C(2)-C(3)              123.98(13)  
            C(4)-C(3)-C(2)              106.70(10)  
            C(5)-C(4)-C(3)              120.45(13)  
            C(4)-C(5)-C(6)              127.38(14)  
            C(13)-C(6)-C(7)             117.91(14)  
            C(13)-C(6)-C(5)             118.40(14)  
            C(7)-C(6)-C(5)              123.67(13)  
            N(1)-C(7)-C(16)             116.07(14)  
            N(1)-C(7)-C(6)              124.33(13)  
            C(16)-C(7)-C(6)             119.02(14)  
            C(14)-C(13)-C(6)            121.52(17)  
            C(15)-C(14)-C(13)           120.30(16)  
            C(16)-C(15)-C(14)           119.64(17)  
            C(15)-C(16)-C(7)            121.42(17)  
           _____________________________________________________________  
   
           Symmetry transformations used to generate equivalent atoms:  





           Table 4.  Bond lengths [A] and angles [deg] for KR21111.  
           _____________________________________________________________  
   
            N(1)-C(2)                     1.2776(18)  
            N(1)-C(7)                     1.3964(19)  
            C(2)-C(21)                    1.489(2)  
            C(2)-C(3)                     1.5236(19)  
            C(3)-C(4)                     1.5137(19)  
            C(3)-C(31)                    1.532(2)  
            C(3)-H(3)                     0.9800  
            C(4)-C(5)                     1.344(2)  
            C(4)-C(41)                    1.482(2)  
            C(5)-C(6)                     1.451(2)  
            C(5)-H(5)                     0.9300  
            C(6)-C(13)                    1.403(2)  
            C(6)-C(7)                     1.413(2)  
            C(7)-C(16)                    1.403(2)  
            C(21)-C(26)                   1.383(2)  
            C(21)-C(22)                   1.390(2)  
            C(22)-C(23)                   1.377(3)  
            C(22)-H(22)                   0.9300  
            C(23)-C(24)                   1.362(3)  
            C(23)-H(23)                   0.9300  
            C(24)-C(25)                   1.358(3)  
            C(24)-H(24)                   0.9300  
            C(25)-C(26)                   1.390(3)  
            C(25)-H(25)                   0.9300  
            C(26)-H(26)                   0.9300  
            C(41)-C(42)                   1.387(2)  
            C(41)-C(46)                   1.395(2)  
            C(42)-C(43)                   1.381(2)  
            C(42)-H(42)                   0.9300  
            C(43)-C(44)                   1.370(3)  
            C(43)-H(43)                   0.9300  
            C(44)-C(45)                   1.367(3)  
            C(44)-H(44)                   0.9300  
            C(45)-C(46)                   1.380(3)  
            C(45)-H(45)                   0.9300  
            C(46)-H(46)                   0.9300  
            C(31)-H(31A)                  0.9600  
            C(31)-H(31B)                  0.9600  
            C(31)-H(31C)                  0.9600  
            C(13)-C(14)                   1.377(3)  
            C(13)-H(13)                   0.9300  
            C(14)-C(15)                   1.376(3)  
            C(14)-H(14)                   0.9300  
            C(15)-C(16)                   1.374(2)  
            C(15)-H(15)                   0.9300  
            C(16)-H(16)                   0.9300  
   
            C(2)-N(1)-C(7)              125.12(12)  
            N(1)-C(2)-C(21)             116.65(12)  
            N(1)-C(2)-C(3)              123.98(13)  
            C(21)-C(2)-C(3)             119.37(12)  
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            C(4)-C(3)-C(2)              106.70(10)  
            C(4)-C(3)-C(31)             114.68(12)  
            C(2)-C(3)-C(31)             113.05(12)  
            C(4)-C(3)-H(3)              107.4  
            C(2)-C(3)-H(3)              107.4  
            C(31)-C(3)-H(3)             107.4  
            C(5)-C(4)-C(41)             121.12(13)  
            C(5)-C(4)-C(3)              120.45(13)  
            C(41)-C(4)-C(3)             118.41(12)  
            C(4)-C(5)-C(6)              127.38(14)  
            C(4)-C(5)-H(5)              116.3  
            C(6)-C(5)-H(5)              116.3  
            C(13)-C(6)-C(7)             117.91(14)  
            C(13)-C(6)-C(5)             118.40(14)  
            C(7)-C(6)-C(5)              123.67(13)  
            N(1)-C(7)-C(16)             116.07(14)  
            N(1)-C(7)-C(6)              124.33(13)  
            C(16)-C(7)-C(6)             119.02(14)  
            C(26)-C(21)-C(22)           117.37(15)  
            C(26)-C(21)-C(2)            123.47(14)  
            C(22)-C(21)-C(2)            119.15(15)  
            C(23)-C(22)-C(21)           121.20(18)  
            C(23)-C(22)-H(22)           119.4  
            C(21)-C(22)-H(22)           119.4  
            C(24)-C(23)-C(22)           120.38(19)  
            C(24)-C(23)-H(23)           119.8  
            C(22)-C(23)-H(23)           119.8  
            C(25)-C(24)-C(23)           119.83(19)  
            C(25)-C(24)-H(24)           120.1  
            C(23)-C(24)-H(24)           120.1  
            C(24)-C(25)-C(26)           120.4(2)  
            C(24)-C(25)-H(25)           119.8  
            C(26)-C(25)-H(25)           119.8  
            C(21)-C(26)-C(25)           120.78(17)  
            C(21)-C(26)-H(26)           119.6  
            C(25)-C(26)-H(26)           119.6  
            C(42)-C(41)-C(46)           117.26(14)  
            C(42)-C(41)-C(4)            121.86(12)  
            C(46)-C(41)-C(4)            120.87(13)  
            C(43)-C(42)-C(41)           121.19(15)  
            C(43)-C(42)-H(42)           119.4  
            C(41)-C(42)-H(42)           119.4  
            C(44)-C(43)-C(42)           120.33(17)  
            C(44)-C(43)-H(43)           119.8  
            C(42)-C(43)-H(43)           119.8  
            C(45)-C(44)-C(43)           119.73(17)  
            C(45)-C(44)-H(44)           120.1  
            C(43)-C(44)-H(44)           120.1  
            C(44)-C(45)-C(46)           120.26(15)  
            C(44)-C(45)-H(45)           119.9  
            C(46)-C(45)-H(45)           119.9  
            C(45)-C(46)-C(41)           121.22(16)  
            C(45)-C(46)-H(46)           119.4  
            C(41)-C(46)-H(46)           119.4  
            C(3)-C(31)-H(31A)           109.5  
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            C(3)-C(31)-H(31B)           109.5  
            H(31A)-C(31)-H(31B)         109.5  
            C(3)-C(31)-H(31C)           109.5  
            H(31A)-C(31)-H(31C)         109.5  
            H(31B)-C(31)-H(31C)         109.5  
            C(14)-C(13)-C(6)            121.52(17)  
            C(14)-C(13)-H(13)           119.2  
            C(6)-C(13)-H(13)            119.2  
            C(15)-C(14)-C(13)           120.30(16)  
            C(15)-C(14)-H(14)           119.8  
            C(13)-C(14)-H(14)           119.8  
            C(16)-C(15)-C(14)           119.64(17)  
            C(16)-C(15)-H(15)           120.2  
            C(14)-C(15)-H(15)           120.2  
            C(15)-C(16)-C(7)            121.42(17)  
            C(15)-C(16)-H(16)           119.3  
            C(7)-C(16)-H(16)            119.3  
           _____________________________________________________________  
   
           Symmetry transformations used to generate equivalent atoms:  





    Table 5.  Anisotropic displacement parameters (A^2 x 10^3) for KR21111.  
    The anisotropic displacement factor exponent takes the form:  
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    N(1)     53(1)      47(1)      56(1)       1(1)      -7(1)      -5(1)  
    C(2)     49(1)      44(1)      50(1)       5(1)      -8(1)      -4(1)  
    C(3)     52(1)      43(1)      61(1)       3(1)     -10(1)      -3(1)  
    C(4)     43(1)      46(1)      54(1)       4(1)      -5(1)      -6(1)  
    C(5)     50(1)      49(1)      55(1)       6(1)      -4(1)       2(1)  
    C(6)     58(1)      41(1)      56(1)       4(1)       2(1)      -3(1)  
    C(7)     57(1)      41(1)      57(1)       2(1)       1(1)      -8(1)  
    C(21)    52(1)      47(1)      54(1)      11(1)      -3(1)      -2(1)  
    C(22)    55(1)      72(1)      76(1)      -1(1)      -1(1)     -12(1)  
    C(23)    52(1)     108(1)      96(2)       6(1)       0(1)     -14(1)  
    C(24)    58(1)     111(2)      83(1)      22(1)      17(1)      10(1)  
    C(25)    79(1)      97(1)      70(1)      -1(1)       8(1)      15(1)  
    C(26)    60(1)      74(1)      62(1)      -1(1)      -4(1)       4(1)  
    C(41)    41(1)      50(1)      56(1)       0(1)      -1(1)      -2(1)  
    C(42)    53(1)      62(1)      60(1)       5(1)      -3(1)       1(1)  
    C(43)    62(1)      85(1)      56(1)      11(1)      -1(1)      -1(1)  
    C(44)    62(1)      96(1)      54(1)     -14(1)      -1(1)      -3(1)  
    C(45)    84(1)      63(1)      72(1)     -13(1)      -7(1)      -5(1)  
    C(46)    77(1)      55(1)      61(1)       0(1)      -8(1)      -4(1)  
    C(31)    67(1)      60(1)      74(1)      19(1)     -12(1)     -17(1)  
    C(13)    65(1)      48(1)      71(1)       2(1)       4(1)       2(1)  
    C(14)    80(1)      49(1)      74(1)      -3(1)      17(1)       0(1)  
    C(15)    91(1)      55(1)      62(1)      -6(1)       9(1)     -12(1)  
    C(16)    73(1)      54(1)      60(1)      -4(1)      -2(1)     -13(1)  





         Table 6.  Hydrogen coordinates ( x 10^4) and isotropic  
         displacement parameters (A^2 x 10^3) for KR21111.  
   
         ________________________________________________________________  
   
                         x             y             z           U(eq)  
         ________________________________________________________________  
   
          H(3)         9969          9356          2599          62  
          H(5)        11622          8080          3192          62  
          H(22)        7474          8478           866          81  
          H(23)        5894          8725          1559         102  
          H(24)        5703          9274          3350         101  
          H(25)        7092          9583          4450          98  
          H(26)        8693          9351          3753          78  
          H(42)       11054          8215          5328          70  
          H(43)       11411          8527          7431          81  
          H(44)       11582          9413          7795          85  
          H(45)       11409          9988          6047          88  
          H(46)       11081          9683          3931          77  
          H(31A)      11326          9478          1161         100  
          H(31B)      10325          9469           328         100  
          H(31C)      11029          8975           352         100  
          H(13)       12374          7606          1343          74  
          H(14)       12254          7230          -732          81  
          H(15)       10854          7376         -2047          83  
          H(16)        9532          7860         -1224          75  





         Table 7.  Torsion angles [deg] for KR21111.  
         ________________________________________________________________  
   
          C(7)-N(1)-C(2)-C(21)                               -172.64(13)  
          C(7)-N(1)-C(2)-C(3)                                   8.0(2)  
          N(1)-C(2)-C(3)-C(4)                                 -69.45(18)  
          C(21)-C(2)-C(3)-C(4)                                111.21(14)  
          N(1)-C(2)-C(3)-C(31)                                 57.52(18)  
          C(21)-C(2)-C(3)-C(31)                              -121.82(14)  
          C(2)-C(3)-C(4)-C(5)                                  62.00(17)  
          C(31)-C(3)-C(4)-C(5)                                -63.99(18)  
          C(2)-C(3)-C(4)-C(41)                               -119.48(13)  
          C(31)-C(3)-C(4)-C(41)                               114.53(14)  
          C(41)-C(4)-C(5)-C(6)                                177.91(13)  
          C(3)-C(4)-C(5)-C(6)                                  -3.6(2)  
          C(4)-C(5)-C(6)-C(13)                                152.80(15)  
          C(4)-C(5)-C(6)-C(7)                                 -28.8(2)  
          C(2)-N(1)-C(7)-C(16)                               -149.86(14)  
          C(2)-N(1)-C(7)-C(6)                                  39.0(2)  
          C(13)-C(6)-C(7)-N(1)                                168.55(13)  
          C(5)-C(6)-C(7)-N(1)                                  -9.9(2)  
          C(13)-C(6)-C(7)-C(16)                                -2.33(19)  
          C(5)-C(6)-C(7)-C(16)                                179.26(13)  
          N(1)-C(2)-C(21)-C(26)                               161.01(14)  
          C(3)-C(2)-C(21)-C(26)                               -19.6(2)  
          N(1)-C(2)-C(21)-C(22)                               -18.1(2)  
          C(3)-C(2)-C(21)-C(22)                               161.28(13)  
          C(26)-C(21)-C(22)-C(23)                               1.6(2)  
          C(2)-C(21)-C(22)-C(23)                             -179.22(17)  
          C(21)-C(22)-C(23)-C(24)                              -1.1(3)  
          C(22)-C(23)-C(24)-C(25)                               0.1(3)  
          C(23)-C(24)-C(25)-C(26)                               0.5(3)  
          C(22)-C(21)-C(26)-C(25)                              -1.1(2)  
          C(2)-C(21)-C(26)-C(25)                              179.80(16)  
          C(24)-C(25)-C(26)-C(21)                               0.1(3)  
          C(5)-C(4)-C(41)-C(42)                               -33.7(2)  
          C(3)-C(4)-C(41)-C(42)                               147.82(13)  
          C(5)-C(4)-C(41)-C(46)                               145.00(15)  
          C(3)-C(4)-C(41)-C(46)                               -33.5(2)  
          C(46)-C(41)-C(42)-C(43)                              -0.4(2)  
          C(4)-C(41)-C(42)-C(43)                              178.35(14)  
          C(41)-C(42)-C(43)-C(44)                               0.6(3)  
          C(42)-C(43)-C(44)-C(45)                              -0.3(3)  
          C(43)-C(44)-C(45)-C(46)                              -0.3(3)  
          C(44)-C(45)-C(46)-C(41)                               0.6(3)  
          C(42)-C(41)-C(46)-C(45)                              -0.3(3)  
          C(4)-C(41)-C(46)-C(45)                             -178.98(17)  
          C(7)-C(6)-C(13)-C(14)                                 4.2(2)  
          C(5)-C(6)-C(13)-C(14)                              -177.27(14)  
          C(6)-C(13)-C(14)-C(15)                               -2.1(2)  
          C(13)-C(14)-C(15)-C(16)                              -2.1(2)  
          C(14)-C(15)-C(16)-C(7)                                4.0(2)  
          N(1)-C(7)-C(16)-C(15)                              -173.32(13)  
          C(6)-C(7)-C(16)-C(15)                                -1.7(2) 
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